← Leaderboards
Patricia Janet Sime
University Of Rochester
$8,180,472
Attributed
$9,818,872
Total exposure
8
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2005–24$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$9,818,872 · 8
By mechanism
R01$7,068,060 · 4
T32$1,652,915 · 1
K08$637,025 · 1
R43$306,872 · 1
R03$154,000 · 1
Top collaborators
- Richard P. Phipps5 shared
- Jacqueline Patricia Williams4 shared
- Cathy A Swindlehurst1 shared
- Thomas Henry Thatcher1 shared
Most similar at University Of Rochester
Same institution · by research overlap
- Thomas A Gasiewicz$24,015,628
- Jacqueline Patricia Williams$6,238,363
- Junfeng Zhang$17,971,883
- Jacob N Finkelstein$12,366,070
- Richard P. Hill$3,931,855
Others in their field
Top investigators on “Fibroblasts”
- Tatiana M. Foroud · Indiana Univ-Purdue Univ At Indianapolis$57,068,242
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$37,747,421
- Joseph C Wu · Stanford University$36,488,088
- Kristin Ardlie · Genomics Collaborative, Inc.$34,108,405
- Gail V Anderson · La Biomed Res Inst/ Harbor Ucla Med Ctr$27,497,410
- Joseph E Robertson · Oregon Health & Science University$27,496,135
Research focus
FibroblastsLungInflammationProductionIn VivoCytokinePathway InteractionsIn VitroCellsMediatingTranscription FactorLung InflammationBreathingLung DiseasesEpithelial CellsAffectFibrogenesisPreventMacrophageReceptorExposure ToPredispositionMalignant NeoplasmsGenetic
Grant awards (33)
Novel oral small molecules for progressive pulmonary fibrosis$306,872
R43 · FY2024 · HL
R01 Transfer from U. of Rochester- Lactate Promotes Scarring After Irradiation$385,000
R01 · FY2019 · HL · contact PI
MULTIDISCIPLINARY TRAINING IN PULMONARY RESEARCH$485,077
T32 · FY2018 · HL · contact PI
Lactate promotes scarring after irradiation$385,000
R01 · FY2018 · HL · contact PI
MULTIDISCIPLINARY TRAINING IN PULMONARY RESEARCH$473,979
T32 · FY2017 · HL · contact PI
Novel therapies for cigarette smoke induced lung injury$389,385
R01 · FY2017 · HL · contact PI
Lactate promotes scarring after irradiation$384,375
R01 · FY2017 · HL · contact PI
Novel therapies for cigarette smoke induced lung injury$389,385
R01 · FY2016 · HL · contact PI
Lactate promotes scarring after irradiation$383,750
R01 · FY2016 · HL · contact PI
Novel therapies for cigarette smoke induced lung injury$383,515
R01 · FY2015 · HL · contact PI
Multidisciplinary Training in Pulmonary Research$235,622
T32 · FY2015 · HL · contact PI
Multidisciplinary Training in Pulmonary Research$458,237
T32 · FY2014 · HL · contact PI
Novel therapies for cigarette smoke induced lung injury$402,612
R01 · FY2014 · HL · contact PI
Role of the Aryl Hydrocarbon Receptor in Lung Inflammation$381,150
R01 · FY2012 · HL · contact PI
Role of the Aryl Hydrocarbon Receptor in Lung Inflammation$385,000
R01 · FY2011 · HL · contact PI
Role of the Aryl Hydrocarbon Receptor in Lung Inflammation$385,000
R01 · FY2010 · HL · contact PI
Role of the Aryl Hydrocarbon Receptor in Lung Inflammation$385,000
R01 · FY2009 · HL · contact PI
Modulation of Silica-Induced Pulmonary Fibrosis$369,790
R01 · FY2009 · HL · contact PI
Modulation of Silica-Induced Pulmonary Fibrosis$199,861
R01 · FY2009 · HL · contact PI
Pathways to Fibrosis$77,000
R03 · FY2009 · HL · contact PI
Role of the Aryl Hydrocarbon Receptor in Lung Inflammation$20,618
R01 · FY2009 · HL · contact PI
Modulation of Silica-Induced Pulmonary Fibrosis$20,288
R01 · FY2009 · HL · contact PI
Role of the Aryl Hydrocarbon Receptor in Lung Inflammation$385,000
R01 · FY2008 · HL · contact PI
Modulation of Silica-Induced Pulmonary Fibrosis$369,790
R01 · FY2008 · HL · contact PI
Pathways to Fibrosis$77,000
R03 · FY2008 · HL · contact PI
Modulation of Silica-Induced Pulmonary Fibrosis$369,790
R01 · FY2007 · HL · contact PI
Modulation of Silica-Induced Pulmonary Fibrosis$342,751
R01 · FY2006 · HL · contact PI
Modulation of Silica-Induced Pulmonary Fibrosis$351,000
R01 · FY2005 · HL
TGFB AND GENE THERAPY IN SILICA INDUCED LUNG FIBROSIS$126,914
K08 · FY2005 · HL
TGFB AND GENE THERAPY IN SILICA INDUCED LUNG FIBROSIS$126,914
K08 · FY2004 · HL
TGFB AND GENE THERAPY IN SILICA INDUCED LUNG FIBROSIS$128,559
K08 · FY2003 · HL
TGFB AND GENE THERAPY IN SILICA INDUCED LUNG FIBROSIS$127,724
K08 · FY2002 · HL
TGFB AND GENE THERAPY IN SILICA INDUCED LUNG FIBROSIS$126,914
K08 · FY2001 · HL